Cargando…

COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality

Introduction Patients with hematological malignancies (HM) are uniquely immunocompromised and considered at high risk for COVID-19. However, data regarding the diagnosis, clinical course, treatment, and outcomes of these patients is sparse. In particular, the ability to successfully detect SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Alex, Ning, Bo, Socola, Francisco, Safah, Hana, Reynolds, Tim, Ibrahim, Moayed, Safa, Firas, Alfonso, Tina, Luk, Alfred, Mushatt, David M, Hu, Tony, Saba, Nakhle S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	203.Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330249/ http://dx.doi.org/10.1182/blood-2020-138611

Ejemplares similares

Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases
por: Cattaneo, Chiara, et al.
Publicado: (2020)

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study
por: De Ramón, Cristina, et al.
Publicado: (2020)

Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance
por: Maia, Catarina, et al.
Publicado: (2020)

Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection
por: Lutfi, Forat, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain
por: Cabirta, Alba, et al.
Publicado: (2020)

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia
por: Motabi, Ibraheem H, et al.
Publicado: (2016)

Rapid Reduction of Anti-Sars-Cov-2 Antibodies in Convalescent Plasma Donors; Results of a Phase 2 Clinical Study
por: Terpos, Evangelos, et al.
Publicado: (2020)

CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C
por: Utley, Adam, et al.
Publicado: (2020)

COVID-19: B-Cell Depletion and Sepsis Related Changes in Bone Marrow and Spleen
por: Ihlow, Jana, et al.
Publicado: (2020)

The Correlation between Absolute Lymphocyte Counts and Clinical Outcomes in COVID-19 Patients
por: Goldberg, Mayer, et al.
Publicado: (2020)

The ACE2 Receptor for COVID-19 Entry Is Expressed on the Surface of Hematopoietic Stem/Progenitor Cells and Endothelial Progenitors As Well As Their Precursor Cells and Becomes Activated in Nlrp3 Inflammasome-Dependent Manner By Virus Spike Protein - a Potential Pathway Leading to a “Cytokine Storm”
por: Kucia, Magdalena, et al.
Publicado: (2020)

Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City
por: Salib, Christian, et al.
Publicado: (2020)

High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies()
por: Niu, Alex, et al.
Publicado: (2021)

Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial
por: Charania, Asad, et al.
Publicado: (2021)

A Multicompartment Mathematical Model Based on Host Immunity for Dissecting COVID-19 Heterogeneity
por: Wu, Jianghua, et al.
Publicado: (2021)

Vaccine Efficacy after Rituximab Exposure: First Interim Analysis of Virtue Project on Behalf of West Midlands Research Consortium, UK
por: Shields, Adrian M, et al.
Publicado: (2021)

Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19
por: Corona De Lapuerta, Magdalena, et al.
Publicado: (2021)

Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma
por: Shree, Tanaya, et al.
Publicado: (2021)

Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections
por: Singh, Aditi, et al.
Publicado: (2021)

Lymphocyte Ratios Progressively Worsen in Non-Survivors of COVID-19
por: Alagbe, Adekunle Emmanuel, et al.
Publicado: (2021)

Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia
por: Rial-Villavecchia, Abora, et al.
Publicado: (2021)

Kinetics of Anti-Sars-Cov-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers
por: Terpos, Evangelos, et al.
Publicado: (2021)

Prevalence of Allelic Variants and Clonality of IGHV1-69 Expressing B-Cells in Patients with Different Severity of COVID 19 Disease
por: Panovska-Stavridis, Irina, et al.
Publicado: (2021)

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
por: Niu, Alex, et al.
Publicado: (2020)

Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy
por: Ibrahim, Moayed, et al.
Publicado: (2021)

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 – VERITAS study
por: Mauro, Francesca R., et al.
Publicado: (2023)

A Case of Suspected Covid 19 Related Cardiomyopathy
por: Miller, Tamari A., et al.
Publicado: (2020)

Facteurs prédictifs du syndrome de l’épuisement professionnel chez les professionnels de la santé
por: Maamri, H., et al.
Publicado: (2022)

Comparison Of Hospital Outcomes Between Covid 19 Myocarditis And Non-covid-19 Myocarditis
por: Carcamo, Francisco Javier Jimenez, et al.
Publicado: (2023)

Practical challenges for functional validation of STAT1 gain of function genetic variants
por: Albuquerque, Adriana S, et al.
Publicado: (2023)

Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients
por: Brown, Jennifer R., et al.
Publicado: (2021)

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
por: Moreno, Carol, et al.
Publicado: (2022)

B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia
por: Schmid, Vera Kristin, et al.
Publicado: (2022)

A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib
por: Mato, Anthony R., et al.
Publicado: (2022)

Sialylation regulates migration in chronic lymphocytic leukemia
por: Natoni, Alessandro, et al.
Publicado: (2023)

A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements
por: McCafferty, Neil, et al.
Publicado: (2022)

Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia
por: Lütge, Almut, et al.
Publicado: (2023)

Interleukin-27 potentiates CD8(+) T-cell-mediated antitumor immunity in chronic lymphocytic leukemia
por: Pagano, Giulia, et al.
Publicado: (2023)

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy
por: Arruga, Francesca, et al.
Publicado: (2023)

The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the literature
por: Ibrahim, Moayed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nffnv1d03ho43l08cp9id0aj2r